Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy

Photochemistry and Photobiology

Volumn 80, Issue 2, 2004, Pages 242-249

  Moriyama, Eduardo H ^a,b   Bisland, Stuart K ^a   Lilge, Lothar ^a   Wilson, Brian C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTO DE PESQUISA E DESENVOLVIMENTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOTOXICITY; GENE; GENETIC TRANSFECTION; GLIOSARCOMA; LUCIFERASE GENE; NONHUMAN; PHOTODYNAMIC THERAPY; RAT; SOLID TUMOR; TUMOR GROWTH;

AMINOLEVULINIC ACID; ANIMALS; CELL SURVIVAL; FEMALE; GLIOSARCOMA; LUMINESCENT MEASUREMENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; RATS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA;

EID: 9144270539     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2004-02-20-RA-088.1     Document Type: Article

References (58)

1. Dougherty, T. J. (2002) An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20, 3-7.
2. Henderson, B. W. and T. J. Dougherty (1992) How does photodynamic therapy work? Photochem. Photobiol. 55, 777-779.
3. Fingar, V. H., T. J. Wieman, S. A. Wiehle and P. B. Cerrito (1992) The role of microvascular damage in photodynamic therapy. The effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 52, 4914-4921.
4. Lilge, L. and B. C. Wilson (1998) Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J. Clin. Laser Med. Surg. 16, 81-91.
5. Muller, P. J. and B. C. Wilson (1995) Photodynamic therapy for recurrent supratentorial gliomas. Semin. Surg. Oncol. 11, 346-354.
6. Lilge, L., M. C. Olivo, S. W. Schatz, J. A. McGuire, M. S. Patterson and B. C. Wilson (1996) The sensitivity of normal brain and intracranial implanted VX2 tumour to interstitial photodynamic therapy. Br. J. Cancer 73, 332-343.
7. Chopp, M., M. O. Dereski, V. Madigan, F. Jiang and B. Logie (1996) Sensitivity of 9L gliosarcomas to photodynamic therapy. Radiat. Res. 146, 461-465.
8. Jiang, F., L. Lilge, J. Grenier, Y. Li, M. D. Wilson and M. Chopp (1997) Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered Photofrin. Lasers Surg. Med. 22, 74-78.
9. Jiang, F., L. Lilge, B. Logie, Y. Liand and M. Chopp (1997) Photodynamic therapy of 9L gliosarcoma with liposome-delivered Photofrin. Photochem. Photobiol. 65, 701-706.
10. Kaye, A. H., G. Morstyn and D. Brownbill (1987) Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a phase 1-2 study. J. Neurosurg. 67, 500-505.
11. Olivo, M. and B. C. Wilson (2004) Mapping ALA-PPK fluorescence in normal brain and brain tumour using confocal fluorescence microscopy. Int. J. Oncol. 25, 37-45.
12. Wilson, B. C., L. D. Lilge, S. K. Bisland, A. Bogaards and P. Muller (2003) Pre-clinical studies of metronomic photodynamic therapy (mPDT) using ALA-PpIX for selective apoptosis of intracranial malignant glioma. Proc. SPIE 4952, 23-31.
13. Bisland, S. K., L. Lilge, A. Lin, R. Rusnov and B. C. Wilson (2004) Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem. Photobiol. 80, 22-30.
14. Wilson, B. C., M. S. Patterson and L. Lilge (1997) Implicit and explicit dosimetry in photodynamic therapy, a new paradigm. Lasers Med. Sci. 12, 182-199.
15. Powers, S. K., S. S. Cush, D. L. Walstad and L. Kwock (1991) Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. Neurosurgery 29, 688-695.
16. Yeung, I., L. D. Lilge and B. C. Wilson (1997) Photodynamic therapy (PDT) induced alterations of the blood-brain-barrier transfer constant of a tracer molecule in normal brain. Proc. SPIE 2972, 54-63.
17. Yang, V. X. D., G. J. Gzarnota, I. A. Vitkin, M. Kolios, M. Sherar, J. de Boer, B. Tromberg and B. C. Wilson (2002) Ultrasound backscatter microscopy/spectroscopy and optical coherence (Doppler) tomography for mechanism-specific monitoring of photodynamic therapy in vivo and in vitro. Proc. SPIE 4612, 128-135.
18. Moore, J. V., M. L. Waller, S. Zhao, N. J. Dodd, P. D. Acton, A. P. Jeavons and D. L. Hastings (1998) Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography. Eur. J. Nucl. Med. 25, 1248-1254.
19. Molckovsky, A. and B. C. Wilson (2001) Monitoring of cell and tissue responses to photodynamic therapy by electrical impedance spectroscopy. Phys. Med. Biol. 46, 983-1002.
20. Gersing, E., D. K. Kelleher and P. Vaupel (2003) Tumour tissue monitoring during photodynamic and hyperthermic treatment using bioimpedance spectroscopy. Physiol. Meas. 24, 625-637.
21. Wang, I., S. Andersson-Engels, G. E. Nilsson, K. Wardell and K. Svanberg (1997) Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging. Br. J. Dermatol. 136, 184-189.
22. Jacques, S. L., J. A. Viator and G. Paltauf (2000) Optoacoustic imaging of tissue blanching during photodynamic therapy of esophageal cancer. Proc. SPIE 3916, 322-330.
23. Chen, Z., T. E. Milner, X. Wang, S. Srinivas and J. S. Nelson (1998) Optical Doppler tomography, imaging in vivo blood flow dynamics following pharmacological intervention and photodynamic therapy. Photochem. Photobiol. 67, 56-60.
24. Yang, V. X. D., M. L. Gordon, B. Qi, E. S. Yue, S. Tang, S. Bisland, J. Pekar, S. Lo, N. Marcon, B. C. Wilson and I. A. Vitkin (2003) High sensitivity detection and monitoring of microcirculation using cutaneous and catheter probes for Doppler optical coherence tomography. Proc. SPIE 4965, 153-159.
25. Wilson, B. C., R. A. Weersink and L. Lilge (2003) Fluorescence in photodynamic therapy dosimetry. In Handbook of Biomedical Fluorescence (Edited by M. A. Mycek and B. W. Pogue), pp. 529-561. Marcel Dekker Inc., New York.
26. Zeng, H., M. Korbelik, D. I. McLean, C. MacAulay and H. Lui (2002) Monitoring photoproduct formation and photobleaching by fluorescence spectroscopy has the potential to improve PDT dosimetry with a verteporfin-like photosensitizer. Photochem. Photobiol. 75, 398-405.
27. Contag, P. R., I. N. Olomu, D. K. Stevenson and C. H. Contag (1998) Bioluminescent indicators in living mammals. Nat. Med. 4, 245-247.
28. Contag, C. H., D. Jenkins, P. R. Contag and R. S. Negrin (2000) Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2, 41-52.
29. Zhang, L., K. E. Hellstrom and L. Chen (1994) Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin. Exp. Metastasis 12, 87-92.
30. Rice, B. W., M. D. Cable and M. B. Nelson (2001) In vivo imaging of light-emitting probes. J. Biomed. Opt. 6, 432-440.
31. Hilali, N., N. Rubio, M. Martinez-Villacampa and J. Blanco (2002) Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases. Lab. Invest. 82, 1563-1571.
32. Contag, C. H. and B. D. Ross (2002) It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J. Magn. Reson. Imaging 16, 378-387.
33. Rehemtulla, A., L. D. Stegman, S. J. Cardozo, S. Gupta, D. E. Hall, C. H. Contag and B. D. Ross (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2, 491-495.
34. Negrin, R. S., M. Edinger, M. Vemeris, Y. A. Cao, M. Bachmann and C. H. Contag (2002) Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence. Ann. Hematol. 81, 44-45.
35. Edinger, M., Y. A. Cao, M. R. Vemeris, M. H. Bachmann, C. H. Contag and R. S. Negrin (2003) Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101, 640-648.
36. Schlosser, V., O. R. Koechli, R. Cattaneo, B. Jentsch, U. Haller and H. Walt (1999) Photodynamic effects in vitro in fresh gynecologic tumors analyzed with a bioluminescence method. Clin. Chem. Lab. Med. 37, 115-120.
37. Hamblin, M. R., D. A. O'Donnell, N. Murthy, C. H. Contag and T. Hasan (2002) Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem. Photobiol. 75, 51-57.
38. Hamblin, M. R., T. Zahra, C. H. Contag, A. T. McManus and T. Hasan (2003) Optical monitoring and treatment of potentially lethal wound infections in vivo. J. Infect. Dis. 187, 1717-1725.
39. Chopp, M., M. O. Dereski, L. Madigan, F. Jiang and B. Logie (1996) Sensitivity of 9L gliosarcomas to photodynamic therapy. Radiat. Res. 146, 461-465.
40. Shevchuk, I., V. Chekulayev, J. Moan and K. Berg (1996) Effects of the inhibitors of energy metabolism, lonidamine and levamisole, on 5-aminolevulinic-acid-induced photochemotherapy. Int. J. Cancer 67, 791-799.
41. Lilge, L., K. Menzies, S. Bisland, A. Lin and B. C. Wilson (2002) PDT induced apoptosis: investigations using two malignant brain tumor models. Proc. SPIE 4612, 136-142.
42. Gibson, S. L., M. L. Nguyen, J. J. Havens, A. Barbarin and R. Hilf (1999) Relationship of delta-aminolevulinic acid-induced protoporphyrin IX levels to mitochondrial content in neoplastic cells in vitro. Biochem. Biophys. Res. Commun. 265, 315-321.
43. Tsujimoto, Y. (1997) Apoptosis and necrosis: Intracellular ATP level as a determinant for cell death modes. Cell Death Differ 4, 429-424.
44. Lilge, L., M. Portnoy and B. C. Wilson (2000) Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue. Br. J. Cancer 83, 1110-1117.
45. Sherf, B. A. and K. Y. Wood (1994) Firefly luciferase engineered to improve genetic reporting. Promega Notes 49, 14-24.
46. Omiya, Y., T. Hirano and M. Ohashi (1996) The structural origin of the color differences in the bioluminescence of firefly luciferase. FEBS Lett. 384, 83-86.
47. Chen, Q., Z. Huang, D. Luck, J. Beckers, P. H. Brun, B. C. Wilson, A. Scherz, Y. Salomon and F. W. Hetzel (2002) Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WSR09) photosensitizer for photodynamic therapy of prostate cancers. Photochem. Photobiol. 76, 438-445.
48. Granville, D. J., J. G. Levy and D. W. Hunt (1997) Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Differ. 4, 623-628.
49. Hanlon, J. G., K. Adams, A. J. Rainbow, R. S. Gupta and G. Singh (2001) Induction of Hsp60 by Photofrin-mediated photodynamic therapy. J. Photochem. Photobiol. B: Biol. 64, 55-61.
50. Wang, H. P., J. G. Hanlon, A. J. Rainbow, M. Espiritu and G. Singh (2002) Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress. Photochem. Photobiol. 76, 98-104.
51. Mitra, S., E. M. Goren, J. G. Frelinger and T. H. Foster (2003) Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo. Photochem. Photobiol. 78, 615-622.
52. Shibata, T., N. Akiyama, M. Noda, K. Sasai and M. Hiraoka (1998) Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes. Int. J. Radiat. Oncol. Biol. Phys. 42, 913-916.
53. Ferrario, A., K. F. von Tiehl, N. Rucker, M. A. Schwarz, P. S. Gill and C. J. Gomer (2000) Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 60, 4066-4069.
54. Wang, G. L. and G. L. Semenza (1995) Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237.
55. Bogaards, A., A. Varma, E. H. Moriyama, A. Lin, A. Giles, S. Bisland, L. Lilge, G. M. Bilbao, P. J. Muller and B. C. Wilson (2003) Fluorescence-guided resection of intracranial VX2 tumor in a preclinical model using 5-aminolevulinic acid (ALA), preliminary results. Proc. SPIE 4952, 91-96.
56. Stummer, W., A. Novotny, H. Stepp, C. Goetz, K. Bise and H. J. Reulen (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins, a prospective study in 52 consecutive patients. J. Neurosurg. 93, 1003-1013.
57. Shinoda, J., H. Yano, S. Yoshimura, A. Okumura, I. Kaku and N. S. Sakai (2003) Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. J. Neurosurg. 99, 597-603.
58. Yang, V. X., P. J. Muller, P. Herman and B. C. Wilson (2003) A multispectral fluorescence imaging system, design and initial clinical tests in intra-operative Photofrin-photodynamic therapy of brain tumors. Lasers Surg. Med. 32, 224-232.